abstract BACKGROUND: Pediatric sleep disordered breathing is often caused by hypertrophy of the tonsils and is commonly managed by tonsillectomy. There is controversy regarding which postsurgical analgesic agents are safe and efficacious.
WHAT'S KNOWN ON THIS SUBJECT: Sleep apnea is a common condition in childhood, mainly managed by tonsillectomy. Codeine was recently contraindicated for pain management after surgery. Controversy exists regarding the safety and effectiveness of alternative medications, morphine, and ibuprofen.
WHAT THIS STUDY ADDS: Our findings suggest that ibuprofen does not increase tonsillar bleeding and in combination with acetaminophen is effective for pain management after tonsillectomy. Furthermore, standard morphine doses increased postoperative respiratory events and were not safe in all children. Sleep disordered breathing (SDB) is characterized by a disruption in ventilation and breathing patterns during sleep. SDB ranges in severity from snoring to obstructive sleep apnea (OSA). 1 During sleep, children who have SDB have recurrent episodes of full or partial airway obstruction resulting in hypoxemia, hypercarbia, and sleep disruption. 2 In children, SDB is often caused by hypertrophy of the tonsils and/or adenoids and is commonly managed by tonsillectomy with or without adenoidectomy. 3 The pain associated with this procedure is moderate to severe and more than 500 000 tonsillectomies are performed on children in the United States every year. 1, 4 Clinical practice guidelines for post-tonsillectomy pain management recommend educating parents on assessing pain in their children, maintaining proper hydration, and maintaining adequate analgesia, especially in the first few postoperative days. 1 Until recently, codeine was commonly prescribed for postoperative pain management in many North American centers. However, on August 15, 2012 , after the publication of 3 codeine-related fatalities posttonsillectomy, the US Federal Drug Administration issued a Drug Safety communication advising practitioners that codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare but life-threatening respiratory failure and death. Further investigation revealed 13 cases of death or lifethreatening overdose in children receiving standard, appropriate codeine doses and the majority of these cases (8/13) were related to tonsillectomy patients. 5 Although the Boxed Warning suggests avoiding codeine for posttonsillectomy pain management, no recommendations have been made as to safe and effective alternate analgesic in pediatric patients. Owing to a fear of increased bleeding, many surgeons have been hesitant to prescribe nonsteroidal antiinflammatory drugs. Our recent meta-analysis, including more than 1700 children, did not detect an increased risk for bleeding after posttonsillectomy nonsteroidal antiinflammatory drug use. 6 The contraindication of codeine for posttonsillectomy analgesia has resulted in a shift to oral morphine. Presently, the safety and effectiveness of both ibuprofen and morphine in this population is unclear. The objective of this randomized clinical trial is to assess the safety and effectiveness of post-tonsillectomy analgesia with morphine and ibuprofen in children who have SDB.
METHODS

After approval by McMaster
University, The Hospital for Sick Children, and The University of Western Ontario Research Ethics Boards, families were invited to participate in a randomized controlled trial in which their children would receive oral acetaminophen and either morphine or ibuprofen for pain management after tonsillectomy +/2 adenoid removal. Recruitment occurred at the McMaster University Medical Centre in Hamilton, Ontario with an allocation ratio of 1:1 run in parallel. This trial was registered with ClinicalTrials.gov (NCT01680939). The inclusion criteria consisted of children who had SDB aged 1 to 10 years, scheduled for tonsillectomy, with or without adenoidectomy. SDB diagnosis was based on parental history, physical examination, and preoperative sleep oximetry. In addition to parental consent, children above the age of 7 years completed an assent form, acknowledging their willingness to participate. Children were excluded if they had previously undergone (adeno)tonsillectomy, or had asthma, obesity (BMI .30), craniofacial/neuromuscular/ hematologic/cardiac abnormalities, or contraindications to general anesthesia.
At the preoperative appointment, parents were provided with a pulse oximeter (Nellcor-Boulder N-600) including Oximax Max-p sensors to take home. The research team instructed parents on how to properly apply the oximeter to the child the night before surgery. The oximeter was used to monitor respiratory parameters (O 2 saturation and the number of apnea events per night) during sleep. Parents were also instructed to repeat these measurements the night after surgery. The primary outcome measure was changes in respiratory parameters (O 2 saturation and number of apnea events per hour) after surgery. No changes were made to the primary outcome variables or protocol after the commencement of the trial.
During surgery, anesthesia was delivered to all participants via inhalation induction with air/nitrous oxide and sevoflurane, intravenous supplementation with propofol and/or fentanyl 1 to 2 mg/kg, antiemetic prophylaxis with dexamethasone 150 mg/kg and ondansetron 50 mg/kg, acetaminophen suppository 40 mg/kg, and morphine intravenous 100 mg/kg.
Randomization to morphine or ibuprofen was achieved by using a computer-generated algorithm created by the study coordinator. To maintain allocation concealment the research associate who assigned patients had no knowledge of the randomization sequence. The study clinicians and parents were not blinded, as they were required to write and fill their child's prescription. Parents were instructed to give the children acetaminophen (10-15 mg/kg per dose every 4 hours) and ageappropriate doses of morphine (0.2-0.5 mg/kg per dose every 4 hours) or ibuprofen (10 mg/kg per dose every 6 hours) as needed, as indicated in McMaster Children's Hospital and The Hospital for Sick Children. 7, 8 On discontinuation of analgesia, the monitors were returned for data extraction. For both groups, all adverse events were monitored and recorded by the parents. This included any signs of significant oral or nasal bleeding, in which case they were instructed to return to the hospital emergency department for appropriate assessment and management. Pamphlets describing the signs of serious postsurgical bleeding requiring medical examination were provided to the parents. Secondary outcome variables included pain, adverse drug reactions, and tonsillar bleeding.
Analgesic effectiveness was assessed on postoperative Day 1 and Day 5 using the validated Objective Pain Scale, 9, 10 which was recorded by the study researchers in the hospital, and then by the parents at home. The Objective Pain Scale is a validated tool that has been extensively used to compare different analgesic modalities in children (Table 1) . 11 In addition, on Day 1 and Day 5, the child completed a modified Faces Scale, a validated tool (ages 1-14 years), which is also commonly used for pain measurement after adenotonsillectomy. 12 Parents were trained by the research staff on how to complete both pain scales. The number of days for a child to return to preoperative diet and the dosing schedule were returned to the research team, after cessation of analgesia.
An independent Data Safety Monitoring Board was set up before trial commencement. The board was commissioned with performing 1 interim analysis halfway through patient recruitment. Pre-and posttonsillectomy values were compared between the groups by Student's t test or x 2 test as appropriate. Univariate correlations between the number of morphine doses and the preoperative tonsil size with respiratory parameters were obtained by using nonlinear regression analysis.
RESULTS
From September 2012 to January 2014, a total of 91 children were consented to participate in this study (Fig 1) . Demographic characteristics of the cohort can be seen in Table 2 . In January 2014 we conducted an interim analysis, as planned in the original protocol, and the Drug Safety Monitoring Board was convened. Morphine and ibuprofen were used for a mean of 4 postoperative days (4.64 6 1.87 days on ibuprofen; 4.04 6 1.92 days on morphine). The majority of children (65%) received morphine doses of 0.2 mg/kg and 26% received between 0.25 and 0.35 mg/kg. The remaining 2 children received doses equivalent to 0.1 mg/kg. Acetaminophen was used for 4.46 6 1.41 days by those randomized to receive ibuprofen and 4.86 6 1.62 days in the morphine group. On the first postoperative night, with respect to oxygen desaturations, 86% of children did not show improvement in the morphine group, whereas 68% of ibuprofen patients did show improvement (Table 3 ). The number of desaturation events per hour (preoperative to postoperative) was reduced by a mean of 1.79 6 7.57 in the ibuprofen group compared with an average increase of 11.17 6 15.02 in the morphine group with an effect size of 0.96 (P , .01) ( Table 3) . Morphine dose on postoperative day 1 did not correlate with the total number of postoperative desaturation events measured that night (R 2 = 0.10). There were no significant differences in the change in lowest O 2 saturation or the mean O 2 saturation after surgery between the 2 groups (Table 3) . Tonsil size did not correlate with the change in desaturation event rates in either group (r = 20.07; P = .74, ibuprofen; r = 20.20; P = .31, morphine).
Pain scale scores on Day 1 and on Day 5 are presented in Table 4 . Further secondary outcomes measured in both groups included bleeding rates and adverse drug reactions. Tonsillar bleeding was reported in 3 children who received ibuprofen and 2 children who received morphine. One of the children who bled in the ibuprofen group required hospitalization, as did both of the children who bled in the morphine group. Adverse drug events were reported at similar rates by parents in the 2 groups.
One of the children randomized to the morphine group suffered from a severe adverse drug reaction related to O 2 desaturation. She was a 10-year-old (31-kg) child diagnosed with OSA. Her preoperative desaturation rate was 2.22 events/h and her tonsils were grade 4/4. She returned to the hospital the morning after her tonsillectomy after three 6-mg doses of morphine owing to prolonged vomiting, which the parents reported contained blood. She was given intravenous morphine (3 mg) in the hospital and discharged 
DISCUSSION
Our study reveals that for children undergoing tonsillectomy, the standard dose range of morphine analgesia increases the risk for oxygen desaturation in comparison with ibuprofen. Furthermore, no differences in analgesic effectiveness or rates of post-tonsillar hemorrhage were identified between children receiving morphine and those receiving ibuprofen. In young children, tonsillectomy 6 adenoidectomy have been reported to improve SDB, but only in up to 65% of children. [13] [14] [15] Perioperative respiratory complications necessitating a medical intervention may occur in more than 10% of children undergoing adenotonsillectomy, with more than 60% of these occurring in the immediate postoperative period. [16] [17] [18] Desaturations can continue for an unpredictable period of time and in a substantial number of children, possibly owing to prolonged changes in the threshold of response to hypoxemia. Moreover, children can experience laryngospasm, airway swelling, and pulmonary edema, leading to further desaturation and even to respiratory arrest. 14 In such cases, in which apnea is not improved after surgery, providing opioids to relieve pain has the potential to increase respiratory depression, through the action of m and k opioid
FIGURE 1
Recruitment flow diagram created using the CONSORT guidelines. 38 Other reasons for approached patients not being randomized include language barriers and parents asking specifically for morphine (not wanting to be randomized). Patients who did not follow randomization did not take the medication they were randomized to receive. All patients who were allocated to either morphine or ibuprofen were included in the intent-to-treat analysis. Only those who had oximeter data available were included in the primary outcome analysis. receptor agonists decreasing respiratory drive and response to hypoxemia.
There are several factors contributing to the adverse respiratory effects of morphine and other opioids used post-tonsillectomy in children who have SDB. Respiratory comorbidities including unresolved apnea, craniofacial disorders, bronchopneumonia, asthma, obesity, and respiratory tract infections combined with swelling after surgery can further compound the respiratory effects of opioids. Hypercarbia is commonly seen in children who have SDB resulting from an overall decrease in ventilation. This disturbance can be reversed after surgery; however, the rate of recovery and extent of reversal is not well understood. Residual respiratory acidosis after tonsillectomy may increase the delivery of nonionized morphine to the brain, owing to an increase in cerebral blood flow, and has the potential to increase respiratory compromise. 19 In canine studies, hypercarbia has been shown to increase cerebral morphine concentrations, whereas serum morphine levels remained unchanged. 20 Furthermore, morphine requirements for analgesia have been shown to be considerably variable in children, as much as 15-fold in some studies, 21 occasionally necessitating large doses for adequate pain control, which may lead to respiratory depression. The hypothesis that morphine analgesia may eliminate respiratory complications by obviating the large variability seen in codeine metabolism and provide more predictable pharmacodynamic effect is not supported by the current study showing similar, unacceptable rates of postsurgical oxygen desaturations to codeine and hydrocodone. 22 In this study, pain was managed with similar effectiveness by both morphine and ibuprofen. A previous randomized trial assessing ibuprofen and acetaminophen with codeine in 110 children after tonsillectomy found no statistically significant difference in reported pain and satisfactory pain relief, as reported by parents at postoperative follow-up. 23 The primary outcome measure in that study was tonsillar bleeding rates, which, similar to our experience, were also not significantly different between the 2 groups. Given the unpredictable post-tonsillectomy respiratory response to opioids (codeine, morphine, and hydrocodone) and the analgesic effectiveness of ibuprofen, perhaps the time has come to question the postoperative use of all opioids in this population. 24 Limitations of the current study include missing oximeter data in both treatment groups owing to children refusing to sleep with the oximeter on their finger. Yet the available sample size provided sufficient statistical power to show the CNS-depressing risks of the opioid. As well, complete polysomnographic (PSG) data were not obtained for our patients. Although this may have provided more data, it may not have been well tolerated in the immediate postoperative period by children. Although PSG is considered the gold standard for diagnosis of pediatric OSA, nighttime oximetry, with its high positive predictive value, can also be used. [25] [26] [27] In this era of resource-limited 30 Additional previous work has demonstrated that overnight oximetry correlates well with postoperative likelihood of adverse respiratory events, 31, 32 and is useful in determining the indications for (adeno)tonsillectomy. 33 Physiologic factors that have been previously identified as potential contributors to poor posttonsillectomy outcomes include smaller tonsils, narrow epipharyngeal airspace, and maxillary/mandibular protrusions. 13 In this cohort, tonsil size did not correlate with an improvement in the number of desaturation events; airspace diameter and maxillary/ mandibular orientation were not assessed. Finally, although parents were instructed to maintain hydration, fluid intake was not monitored in this cohort. This could potentially have affected pain scores, as inadequate hydration has been shown to increase reported pain after tonsillectomy. 34 As parents were required to fill their prescriptions at their local pharmacy, parental blinding was not included in the study design. This may have introduced bias in parental report of secondary outcomes; however, this would not have an effect on the measurement of the primary outcome. Finally, the reported severe adverse drug reaction is confounded by the administration of intravenous morphine and the comorbid respiratory tract infection.
Preoperative use of diclofenac and gabapentin 35 has been shown to decrease post-tonsillectomy opioid requirements for children older than 10 years of age, and the effectiveness of these medications in young children warrants further investigation. When compared with morphine, tramadol was shown to result in fewer respiratory events post-tonsillectomy 36 ; however, further work is required to assess the safety of tramadol as an alternative analgesic. A retrospective review identified a reduction in recurrent hypoxemia after adenotonsillectomy in children who have severe OSA resulting from dexamethasone administration (∼2.4 mg/kg) and a reduction opioid dose. 37 Future studies should prospectively corroborate these findings and address genetic variability in opioid response by assessing both genotype and plasma drug levels to better characterize which children may be increasingly sensitive to post-tonsillectomy opioids.
CONCLUSIONS
The use of a standard morphine dose range for post-surgical analgesia was associated with increased risk for oxygen desaturation. There were no differences seen in tonsillar bleeding events or in analgesic effectiveness. The results of this study support effective post-tonsillectomy analgesia in children by using ibuprofen in combination with acetaminophen.
